Named on 7 rounds in the feed, most often at Series A and in Biotech.
Rounds from 2022-08-11 to 2026-09-30
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Spark Pediatrics Spark Pediatrics provides medical daycare services specifically designed for children with complex medical needs. | Growth Verified against 3 sources | $35M | 2026-09-30 | [ PART ] |
ai3Bio A biotechnology company targeting autoimmune disease at its root source | Series A Verified against 4 of 14 sources | $48M | 2026-09-29 | [ LEAD ] |
Estuary Biotherapeutics A biotechnology company developing genetic medicines for patients with serious kidney diseases | Series A Verified against 1 of 14 sources | $93M | ~ 2025-05-30 | [ PART ] |
Latigo Biotherapeutics Latigo is a clinical-stage biopharmaceutical company developing innovative non-opioid pain medicines. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $150M | 2025-03-17 | [ PART ] |
Spark Pediatrics Spark Pediatrics provides medical daycare services specifically designed for children with complex medical needs. | Funding round Developing, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $15M | 2025-01-22 | [ LEAD ] |
Ouro Medicines Ouro Medicines develops treatments for immune-mediated diseases, targeting patients with such conditions. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2025-01-10 | [ PART ] |
Abridge Abridge sells an AI-powered clinical documentation platform for healthcare professionals, enhancing the accuracy and efficiency of patient interactions and documentation. | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $12.5M | 2022-08-11 | [ PART ] |